Post by
Davepark5 on Dec 07, 2022 10:26am
Noteable you seem very knowledgeable
about this stock. Why is it getting hit so hard after seemingly good news? typically stocks rise strongly with fast track approval? not following why this stock continues to tank
Comment by
lonc17 on Dec 07, 2022 10:31am
The company has a legal obigation to issue a press release after disclosing material news at SABC. Good or bad, the news is material. If it was good news, the press release would have been bright and early this morning. I'm surprised the stock is not down 25%.
Comment by
SundayMovies on Dec 07, 2022 10:36am
Ionc17, I disagree. You don't go to conference with two negative posters. If the news is bad, you just do a press release saying we failed, we tried, we love you, please love us still some time. I think news will be after hours. I don't care about AWARE-1. It's the Adlai one I care about because of the PR and possible licensing money that goes with it.
Comment by
Quentin30 on Dec 07, 2022 10:38am
well perhaps you should care about AWARE-1.. our CEO stated back in 2018, that all Roche needed to pull the trigger (on a deal) was AWARE-1 results.. yup, that worked out well.